Authors: Mary Clare McCorry, Kenneth F Reardon, Marcie Black, Chrysanthi Williams, Greta Babakhanova, Jeffrey M Halpern, Sumona Sarkar, Nathan S Swami, Katherine A Mirica, Sarah Boermeester and Abbie Underhill
Biofabrication, 27 October 2022
This review summarizes relevant technologies that can be used to monitor the health and phenotype of cells in the process of manufacturing regenerative medicine products. The Axion BioSystems Lux2 is highlighted for its automated cell confluence monitoring ability. The article also mentions the Axion BioSystems Omni as a system that can be placed in a cell culture incubator, being able to capture morphological features of cells and organoids.
